Royal Bank of Canada
CLGN icon

Royal Bank of Canada’s CollPlant Biotechnologies CLGN Stock Holding History

Royal Bank of Canada’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-284
Closed -$1K – 7213
2025
Q3 		$1K Buy
+284
New +$677 ﹤0.01% 6958
2025
Q2 		– Sell
-500
Closed -$1K – 7058
2025
Q1 		$1K Buy
+500
New +$1.76K ﹤0.01% 6639
2021
Q2 		– Sell
-10,000
Closed -$134K – 7497
2021
Q1 		$134K Buy
+10,000
New +$151K ﹤0.01% 5250
2020
Q4 		– Sell
-836
Closed -$7K – 7076
2020
Q3 		$7K Hold
836
– – ﹤0.01% 6037
2020
Q2 		$8K Hold
836
– – ﹤0.01% 5899
2020
Q1 		$8K Buy
+836
New +$8.58K ﹤0.01% 5888

Other funds holding CLGN

SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $1.95B AUM 15.9% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Royal Bank of Canada's CLGN Position: Q4 2025 in Review

Royal Bank of Canada sold out of CollPlant Biotechnologies (CLGN) in Q4 2025, closing a stake of 284 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in CLGN in Q1 2020 and held it in 6 quarters. The position peaked at $134K in Q1 2021. 17 funds tracked by Wall St. Rank hold CLGN as of Q4 2025.

  • Royal Bank of Canada reported no remaining CollPlant Biotechnologies position as of Q4 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 284 CollPlant Biotechnologies shares in Q4 2025, an estimated $1K.
  • Royal Bank of Canada first reported a position in CollPlant Biotechnologies in Q1 2020 and held it in 6 quarters.
  • Royal Bank of Canada's CollPlant Biotechnologies position peaked at $134K in Q1 2021.
  • 17 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q4 2025.

Based on Royal Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.